Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreWe believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreWe are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn More
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreExplore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn MoreOur clinical teams of nurses, pharmacists, phlebotomists, and doctors provide the NHS with clinical capacity to deliver care directly to patients, including triage and scheduling, prehabilitation, testing, care reviews, and treatment administration.
Partnering with the NHS to identify high-risk patients and deliver timely remote, pharmacist-led COPD reviews with Leicester, Leicestershire & Rutland ICB (LLR) to optimise patient care in Chronic Obstructive Pulmonary Disease (COPD) and alleviate pressures on the backlog of care.
Understand the Environment
Quantify the Opportunity
Transform the Pathway
Identify the Patient
Implement the Change
Delivering end-to-end services to ensure patients in the UK get efficient access to pharmaceutical therapeutics and diagnostics.
